The company will distribute its needle-free injection therapy products to medical device groups in Australia, the Republic of the Philippines, and North Africa.
Bioject president and CEO Mark Logomasini said the agreements will expand the use of the company’s needle-free devices throughout the world.
"In partnership with our distributors, we are looking forward to developing relationships with new users of Bioject’s needle-free technology," Logomasini added.
